Veterinary Implants Devices Market by Type (Orthopedic, Cardiovascular, Active Electronic, Drug Delivery), Application (Health Monitoring, Treatment Management), Animal (Companion, Livestock, Performance), End User (Hospitals) - Global Forecast to 2031

Market Size
$0.74B
MARKET SIZE, 2026
Projected Market Size
$0.98B
MARKET SIZE, 2031
CAGR
5.7%
CAGR (2026-2031)
Forecast Period
2026-2031
FORECAST PERIOD

VETERINARY IMPLANT DEVICES MARKET SIZE, SHARE & GROWTH SNAPSHOT

veterinary-implants-devices-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global veterinary implant devices market is projected to grow from USD 0.74 billion in 2026 to USD 0.98 billion by 2031, at a CAGR of 5.7% during the forecast period. The market was valued at USD 0.71 billion in 2025. The market is driven by the growing number of veterinary procedures requiring implantable solutions, particularly among companion animals. Increasing prevalence of orthopedic injuries, degenerative diseases, urinary disorders, and cardiovascular conditions is encouraging veterinarians and animal owners to pursue surgical and interventional treatments that incorporate implants. Beyond companion animals, demand from livestock, performance animals, wildlife, and research animals is broadening the market base. Livestock producers are increasingly using implantable identification and monitoring technologies to support herd management, while research institutions are adopting implantable telemetry and sensing devices for continuous physiological monitoring. At the same time, improvements in veterinary specialty services, greater availability of trained veterinary surgeons, and rising investment in animal healthcare infrastructure are increasing access to implant-based procedures across key markets.

KEY TAKEAWAYS

  • MARKET SNAPSHOT:
    Base Year Market Size (2025): USD 0.71 Billion
    Current Market Size (2026): USD 0.74 Billion
    Forecast Market Size (2031): USD 0.98 Billion
    CAGR (2026–2031): 5.7%
  • SEGMENT LEADERSHIP:
    Regional Leader: North America accounted for a 33.9% share of the global veterinary implant devices market in 2025.
    Fastest-Growing Implant Device: Monitoring, sensing, and diagnostic implants are expected to register a CAGR of 6.8% between 2026 and 2031.
    Animal Type Leader: Companion animals held the largest share of the global veterinary implant devices market in 2025.
    Fastest-Growing Application: Activity, behavior, and performance enhancement is anticipated to exhibit a CAGR of 7.6% during the forecast period.
    End User Leader: Veterinary clinics and hospitals captured a 55.6% market share in 2025.
  • MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
    Star players include Merck & Co., Inc. (US), Elanco (US), Johnson & Johnson (DePuy Synthes) (US), Zoetis Inc (US), Virbac (France), B. Braun SE (Germany), Harvard Biosciences. Inc (Data Science International) (US), Securos Surgical (Cencora, Inc) (US), BioMedtrix, LLC (US), IMEX Veterinary, Inc (Movora) (US), KYON (Movora)(Switzerland), New Generation Devices (NGD)(US), Veterinary Orthopedic Implants (US), Arthrex, Inc (Arthrex Vet Systems) (US), and Infiniti Medical, LLC (US), given their extensive global reach and comprehensive service portfolios.
    Other companies include PH Orthcom (China), Veterinary Instrumentation (UK), Star Oddi (Iceland), Biotronik (Germany), Thema Biotel (Norway), SmaXtec Animal Care Gmbh (Austria), Auxilium MD (Teliatry, Inc.) (US), Biovetsensor (France), Norfolk Vet products (US), and Primetech Corporation (Japan). These companies strengthen their competitive positions by developing specialized veterinary implants, procedure-specific orthopedic and interventional devices, implantable monitoring and sensing technologies, and customized solutions addressing the needs of companion animals, livestock, research institutions, and other specialized veterinary applications.

The global veterinary implant devices market is driven by the increasing adoption of advanced veterinary procedures, rising animal healthcare expenditure, and growing use of implants for orthopedic, cardiovascular, urinary, reproductive, therapeutic, and monitoring applications. Expanding veterinary specialty care and livestock health management are further increasing implant utilization. Advances in 3D-printed, minimally invasive, patient-specific, and wireless implant technologies are improving treatment precision and monitoring capabilities, supporting broader adoption of veterinary implant devices.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

Major trends and disruptions shaped the veterinary implant devices market in 2025, driven by increasing adoption of patient-specific implants, minimally invasive procedures, advanced biomaterials, and implantable monitoring technologies. Expanding applications across companion-animal orthopedics, cardiovascular and interventional procedures, urinary and soft-tissue applications, livestock production, veterinary research, and wildlife monitoring are creating new opportunities, particularly in improved surgical outcomes, continuous animal monitoring, and species-specific treatment. Meanwhile, three-dimensional (3D) printing, artificial intelligence (AI)-enabled surgical planning, wireless telemetry, smart implants, implantable sensors, and digital animal-health platforms are improving implant selection, surgical precision, physiological monitoring, and clinical decision-making. Growing demand for personalized veterinary care, reduced procedure-related complications, continuous animal-health monitoring, and improved research efficiency is also accelerating the development of customized implants, connected monitoring systems, advanced cardiovascular devices, and specialized solutions for livestock, wildlife, and research applications. These developments are shifting the market toward new technologies, products, applications, integrated digital solutions, and specialized veterinary ecosystems.

veterinary-implants-devices-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Rising pet ownership and increasing humanization of companion animals
  • Increasing prevalence of diseases and disorders
RESTRAINTS
Impact
Level
  • High cost of veterinary implant procedures and devices
  • Shortage of trained veterinary surgeons specialized in implant-based procedures
OPPORTUNITIES
Impact
Level
  • Increasing development of 3D-printed, patient-specific veterinary implants and digital surgical planning
  • Expansion of veterinary implant applications in livestock and aquatic animals
CHALLENGES
Impact
Level
  • Clinical complications associated with veterinary implant devices
  • Regulatory and quality compliance complexity for veterinary implant devices

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Rising pet ownership and increasing humanization of companion animals

The growing adoption of pets and increasing humanization of companion animals are driving the demand for veterinary implant devices, particularly across orthopedic, therapeutic, cardiovascular, soft-tissue, and monitoring applications. As pet owners increasingly consider companion animals as family members, spending on advanced veterinary care is rising, including treatments for fractures, joint disorders, ligament injuries, cardiovascular conditions, and chronic diseases. Greater emphasis on improving animal longevity, mobility, quality of life, and recovery is encouraging the adoption of fracture fixation systems, joint replacements, TPLO/TTA implants, implantable drug-delivery systems, cardiac devices, and monitoring implants, supporting continued expansion of the companion animal veterinary implant market.

Restraint: High cost of veterinary implant procedures and devices

The high cost of veterinary implant devices and associated surgical procedures can limit their adoption, particularly for companion animals, where treatment expenses are often borne directly by pet owners. The total cost can include the implant, diagnostic imaging, anesthesia, surgery, hospitalization, and post-operative care, while advanced procedures may also require specialized equipment and trained veterinary surgeons. Limited pet insurance coverage and high out-of-pocket expenses can make advanced implant procedures less affordable, leading some owners to delay treatment or choose lower-cost alternatives, thereby constraining the adoption of high-value veterinary implant devices.

Opportunity: Increasing development of 3D-printed, patient-specific veterinary implants and digital surgical planning

The increasing development of 3D-printed, patient-specific veterinary implants and digital surgical planning is creating opportunities for manufacturers to provide customized solutions for complex orthopedic and skeletal procedures. 3D printing enables implants to be designed according to an animal’s individual anatomy, supporting improved fit and procedure-specific designs for fracture fixation, bone reconstruction, joint replacement, and other complex surgeries. Digital imaging, 3D anatomical modeling, virtual surgical planning, and computer-assisted procedures further enable veterinarians to evaluate anatomy and plan implant placement before surgery. The growing availability of advanced imaging and additive manufacturing technologies is expected to support the development of customized implants and expand the use of personalized veterinary implant solutions.

Challenge: Clinical complications associated with veterinary implant devices

The risk of clinical complications remains a key challenge in the adoption of veterinary implant devices, particularly across orthopedic, cardiovascular, urinary, and other invasive applications. Complications such as infection, inflammation, implant migration or loosening, tissue damage, fracture, rejection, and inadequate healing can occur depending on the implant type, surgical technique, animal condition, and post-operative care. These complications may require additional procedures, implant revision or removal, and extended treatment, increasing the overall cost and clinical burden. Differences in animal anatomy, physiology, activity levels, and healing responses further complicate the prediction of implant performance, requiring appropriate implant selection, surgical expertise, post-operative monitoring, and follow-up care.

VETERINARY IMPLANT DEVICES MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Enables controlled delivery of growth-promoting hormones through veterinary cattle implants, including the Synovex portfolio, across different stages of beef production Supports improved weight gain, feed efficiency, and production performance through sustained implant-based hormone delivery
company logo
Provides sustained-release veterinary implants, including Suprelorin, for controlled hormonal and reproductive management in dogs and ferrets Enables reversible and long-duration reproductive management while reducing the need for repeated treatments or surgical intervention
company logo
Develops veterinary orthopedic implant systems, including total hip replacement, knee, elbow, and fracture fixation systems, designed for companion-animal orthopedic procedures Improves joint reconstruction, skeletal stabilization, and mobility in dogs and other companion animals while supporting treatment of complex orthopedic conditions
company logo
Develops growth-promoting implant technologies, including Revalor implants, for controlled hormone delivery in beef cattle Improves cattle growth and feed efficiency while supporting production-performance management across different livestock production stages
company logo
Develops veterinary orthopedic implant systems, including plates, screws, fracture-fixation systems, and TPLO/TTA solutions for companion animals IImproves cattle growth and feed efficiency while supporting production-performance management across different livestock production stages

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The veterinary implant devices market forms an ecosystem comprising veterinary implant product manufacturers, animal health companies, veterinary hospitals and clinics, research and academic institutions, and regulatory bodies. Key manufacturers and animal health companies such as Zoetis Inc., BioMedtrix, DePuy Synthes, Securos Surgical, Virbac, and Merck provide orthopedic, therapeutic, reproductive, growth-promoting, identification, monitoring, and other veterinary implant solutions. End users include veterinary clinics and hospitals such as VCA and Ringpai Pet Hospital, as well as research and academic institutions such as the Indian Veterinary Research Institute and Iowa State University College of Veterinary Medicine. Regulatory stakeholders, including the US Food and Drug Administration (FDA), European Medicines Agency (EMA), Australian Pesticides and Veterinary Medicines Authority (APVMA), and Ministry of Agriculture and Rural Affairs of the People's Republic of China, establish requirements governing veterinary products and animal health applications. The ecosystem is further supported by veterinary professionals, livestock operations, pharmaceutical and biotechnology companies, and research organizations, driving the development and adoption of advanced implants focused on animal health, treatment outcomes, monitoring, recovery, and long-term care.

veterinary-implants-devices-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

veterinary-implants-devices-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Veterinary Implant Devices Market, By Implant Device

In 2025, orthopedic and skeletal implants held the largest share of the veterinary implant devices market. The segment benefits from the wide range of implant systems used to manage musculoskeletal conditions in companion animals, including fracture fixation plates, screws, pins, joint replacement systems, and TPLO/TTA implants. Growing adoption of specialized orthopedic procedures, improvements in implant design and fixation techniques, and increasing demand for durable, biocompatible implants are supporting the segment. The increasing availability of veterinary orthopedic specialists and advanced surgical facilities is further expanding the use of these devices.

Veterinary Implant Devices Market, By Application

In 2025, orthopedic and fracture repair accounted for the largest share of the veterinary implant devices market. The application covers a range of procedures performed to restore bone stability and mobility following traumatic fractures, cranial cruciate ligament injuries, joint damage, and other musculoskeletal disorders. Rising incidence of orthopedic conditions in companion animals, greater diagnosis of injuries through advanced imaging, and increasing acceptance of surgical intervention are driving procedure volumes. The growing use of minimally invasive and advanced fixation techniques is also supporting demand for implant-based fracture repair.

Veterinary Implant Devices Market, By End User

In 2025, veterinary clinics and hospitals captured the largest share of the veterinary implant devices market. These facilities account for a substantial proportion of implant procedures because they provide the diagnostic, surgical, anesthesia, imaging, and postoperative care required for implant placement. The expansion of specialty and referral hospitals, increasing availability of veterinary orthopedic and surgical specialists, and investment in advanced operating and diagnostic infrastructure are enabling clinics and hospitals to perform more complex implant-based procedures. Their role across multiple implant applications, including orthopedic, cardiovascular, urinary, and soft-tissue procedures, further supports their leading market position.

REGION

Asia Pacific to be fastest-growing region in global veterinary implant devices market during forecast period

During the forecast period, Asia Pacific is expected to register the highest CAGR in the veterinary implant devices market. The region's growth is mainly driven by rising pet ownership, increasing expenditure on animal healthcare, expansion of specialty veterinary hospitals, and growing adoption of advanced orthopedic and surgical procedures in countries such as China, Japan, India, Australia, and South Korea, particularly for fracture fixation, cranial cruciate ligament repair, TPLO, TTA, and joint replacement procedures. Rising pet healthcare expenditure and the expansion of specialty veterinary hospitals are increasing access to these procedures, while improvements in diagnostic imaging and surgical capabilities are enabling more complex implant-based interventions. In parallel, the region's substantial livestock population supports demand for production implants, reproductive implants, identification technologies, and intraruminal and physiological monitoring devices, particularly as commercial livestock operations adopt more data-driven animal-health and production-management practices. The combination of expanding companion-animal specialty care, large-scale livestock production, and improving veterinary infrastructure is expected to accelerate adoption of veterinary implant devices across the region.

veterinary-implants-devices-market Region

VETERINARY IMPLANT DEVICES MARKET: COMPANY EVALUATION MATRIX

Merck & Co., Inc. emerges as a prominent player in the veterinary implant devices market, supported by its broad animal health portfolio, established livestock presence, and expertise in implant-based production and animal identification technologies. Through Merck Animal Health, the company serves livestock and companion-animal markets, with veterinary implants primarily used in cattle production and animal identification and monitoring applications. Merck's position is supported by its revalor cattle implant portfolio. The company's strong position is further supported by its established global commercial infrastructure, extensive livestock customer base, and integration of animal health, production, identification, and monitoring technologies. Merck Animal Health's ability to provide products addressing cattle growth performance strengthens its product footprint across livestock applications. Its established relationships with veterinarians, livestock producers, and animal-health professionals, combined with continued investment in animal health technologies, support its market presence and provide opportunities for further expansion in the veterinary implant devices market. BioMedtrix (US) is a recognized player in the veterinary implant devices market, specializing in orthopedic implants for companion animals. Its portfolio includes hip replacement systems (BFX and CFX), TPLO bone plates, and I-Loc intramedullary fixation systems for treating orthopedic conditions and fractures. The TPLO Curve plate features a silver-based antimicrobial HyProtect coating designed to provide localized infection protection. Through continued product innovation and a specialized focus on companion-animal orthopedics, the company contributes to the advancement of veterinary implant solutions.

veterinary-implants-devices-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 0.71 BN
Market Size in 2026 (Value) USD 0.74 BN
Market Forecast in 2031 (Value) USD 0.98 BN
Growth Rate CAGR of 5.7% from 2026-2031
Years Considered 2024-2031
Base Year 2025
Forecast Period 2026-2031
Units Considered Value (USD Million/Billion), Volume (Thousand/Million Units)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Implant Device:
    • Orthopedic and Skeletal Implants
    • Cardiovascular and Interventional Implants
    • Active Electronic Implants
    • Urinary and Soft Tissue Implants
    • Therapeutic and Drug Delivery Implants
    • Monitoring
    • Sensing
    • and Diagnostic Implants
    • and Other Implant Devices
  • By Application:
    • Orthopedic and Fracture Repair
    • Cardiovascular and Interventional Treatment
    • Health and Wellness Monitoring
    • Activity
    • Behavior
    • and Performance Monitoring
    • Treatment
    • Drug Delivery
    • and Reproductive Management
    • Production Performance Enhancement
    • and Other Applications
  • By Animal Type:
    • Companion Animals
    • Performance and Sport Animals
    • Livestock
    • Wildlife
    • and Conservation Animals
    • Zoo Animals
    • Research Animals
    • and Other Animals
  • By End User:
    • Veterinary Clinics and Hospitals
    • Livestock Farms and Production Operations
    • Pharmaceutical and Biotechnology Companies and Contract Research Organizations
    • Veterinary Research Institutes and Academic Institutions
    • Wildlife and Conservation Organizations
    • and Other End Users
Regions Covered North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

WHAT IS IN IT FOR YOU: VETERINARY IMPLANT DEVICES MARKET REPORT CONTENT GUIDE

veterinary-implants-devices-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Product Analysis Compared key veterinary implant categories, including orthopedic and skeletal, cardiovascular and interventional, urinary and soft-tissue, active electronic, therapeutic/drug-delivery, and monitoring/sensing implants. Evaluated product types, implant materials, fixation technologies, species suitability, procedure applications, clinical requirements, implantation methods, technology maturity, and adoption trends across companion animals, livestock, research, and wildlife applications. Enabled identification of suitable implant technologies, product specifications, clinical requirements, and application benchmarks. Supported decisions related to product portfolio development, technology selection, implant design, product differentiation, and expansion into emerging veterinary applications.
Company Information Profiled major players including Merck & Co., Inc., Elanco, Johnson & Johnson (DePuy Synthes Vet), Zoetis, Virbac, B. Braun, Harvard Bioscience (Data Sciences International), Securos Surgical, BioMedtrix, IMEX Veterinary, KYON, New Generation Devices (NGD), Veterinary Orthopedic Implants, Arthrex Vet Systems, and Infiniti Medical. Provided insights into product portfolios, implant technologies, manufacturing capabilities, application focus, geographic presence, partnerships, acquisitions, R&D activities, and competitive positioning. Provided clarity on competitive positioning, product differentiation, manufacturing capabilities, application expertise, R&D strengths, geographic expansion, and strategic priorities. Supported evaluation of potential technology partners, suppliers, distributors, acquisition targets, and collaboration opportunities across veterinary implant applications.
Geographic Analysis Provided region-by-region analysis of veterinary implant adoption across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, including pet healthcare expenditure, veterinary infrastructure, specialty hospital development, livestock production, implant adoption trends, regulatory environment, clinical capabilities, and investment opportunities. Supported global strategy planning by identifying regional growth opportunities for veterinary implant devices. Helped evaluate market maturity, regulatory requirements, specialist availability, local manufacturing and distribution opportunities, and potential regions for capacity expansion, partnerships, and market entry.

RECENT DEVELOPMENTS

  • May 2026 : Zoetis received expanded US approval for Synovex one grower, extending its use to increase the rate of weight gain in growing beef steers and heifers in dry lots or on pasture with insufficient forage.
  • April 2026 : Arthrex Vet Systems highlighted the use of its OrthoLine distal femur osteotomy system, including plates and screws, to support surgical treatment of a dog with complex femoral fractures, demonstrating the application of its veterinary orthopedic implant portfolio in complex fracture repair.
  • July 2025 : Virbac received marketing authorization in Japan for Suprelorin (deslorelin acetate) implant, expanding availability of its reversible, minimally invasive reproductive-management implant for companion animals.

 

Table of Contents

checkmarkExclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
 
43
2
EXECUTIVE SUMMARY
 
 
 
 
 
49
3
PREMIUM INSIGHTS
 
 
 
 
 
55
4
MARKET OVERVIEW
Surging pet ownership and advanced implants drive market, despite cost and surgeon shortages.
 
 
 
 
 
58
 
4.1
INTRODUCTION
 
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
 
 
4.2.1.1
RISING PET OWNERSHIP AND HUMANIZATION OF COMPANION ANIMALS DRIVING THE MARKET
 
 
 
 
 
 
4.2.1.2
INCREASING PREVALENCE OF DISEASES AND DISORDERS DRIVING DEMAND FOR IMPLANT-BASED TREATMENT
 
 
 
 
 
 
4.2.1.3
GROWING ADOPTION OF ADVANCED VETERINARY SURGICAL PROCEDURES ACCELERATING DEMAND FOR VETERINARY IMPLANTS
 
 
 
 
 
 
4.2.1.4
TECHNOLOGICAL ADVANCEMENTS IN VETERINARY IMPLANT DESIGN AND MATERIALS
 
 
 
 
 
 
4.2.1.5
GROWTH IN SPECIALTY VETERINARY HOSPITALS AND REFERRAL NETWORKS WITH ADVANCED SURGICAL CAPABILITIES
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
 
 
4.2.2.1
HIGH COST OF VETERINARY IMPLANT PROCEDURES AND DEVICES HINDERING MARKET GROWTH
 
 
 
 
 
 
4.2.2.2
SHORTAGE OF TRAINED VETERINARY SURGEONS SPECIALIZED IN IMPLANT-BASED PROCEDURES CONSTRAINING MARKET ADOPTION
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
 
 
4.2.3.1
INCREASING DEVELOPMENT OF 3D-PRINTED, PATIENT-SPECIFIC VETERINARY IMPLANTS AND DIGITAL SURGICAL PLANNING
 
 
 
 
 
 
4.2.3.2
EXPANSION OF VETERINARY IMPLANT APPLICATIONS IN LIVESTOCK AND AQUATIC ANIMALS
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
 
 
 
4.2.4.1
CLINICAL COMPLICATIONS ASSOCIATED WITH VETERINARY IMPLANT DEVICES
 
 
 
 
 
 
4.2.4.2
REGULATORY AND QUALITY COMPLIANCE COMPLEXITY FOR VETERINARY IMPLANT DEVICES
 
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
 
 
 
4.3.1
UNMET NEEDS IN VETERINARY IMPLANT DEVICES MARKET
 
 
 
 
 
 
4.3.2
WHITE SPACE OPPORTUNITIES
 
 
 
 
 
4.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
 
 
4.4.1
INTERCONNECTED MARKETS
 
 
 
 
 
 
4.4.2
CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
 
5
INDUSTRY TRENDS
Explore competitive dynamics and economic shifts shaping the global veterinary healthcare landscape.
 
 
 
 
 
72
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
 
5.1.1
THREAT OF NEW ENTRANTS
 
 
 
 
 
 
5.1.2
THREAT OF SUBSTITUTES
 
 
 
 
 
 
5.1.3
BARGAINING POWER OF BUYERS
 
 
 
 
 
 
5.1.4
BARGAINING POWER OF SUPPLIERS
 
 
 
 
 
 
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
 
5.2
MACROECONOMIC INDICATORS
 
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
 
5.2.2
GDP TRENDS & FORECAST
 
 
 
 
 
 
5.2.3
TRENDS IN GLOBAL VETERINARY HEALTHCARE INDUSTRY
 
 
 
 
 
 
5.2.4
TRENDS IN GLOBAL VETERINARY MEDICAL DEVICE INDUSTRY
 
 
 
 
 
5.3
SUPPLY CHAIN ANALYSIS
 
 
 
 
 
 
 
5.4
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
 
5.5
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
 
5.6
PRICING ANALYSIS
 
 
 
 
 
 
 
 
5.6.1
AVERAGE SELLING PRICE TREND, BY IMPLANT DEVICE TYPE (2023–2025)
 
 
 
 
 
 
5.6.2
AVERAGE SELLING PRICE TREND, BY REGION (2023–2025)
 
 
 
 
 
5.7
TRADE ANALYSIS
 
 
 
 
 
 
 
 
5.7.1
IMPORT DATA (HS CODE 9021)
 
 
 
 
 
 
5.7.2
EXPORT DATA (HS CODE 9021)
 
 
 
 
 
 
5.7.3
LIMITATIONS OF HS CODE 9021 AS A PROXY FOR VETERINARY IMPLANT TRADE
 
 
 
 
 
5.8
KEY CONFERENCES & EVENTS, 2026–2027
 
 
 
 
 
 
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
 
 
5.10
INVESTMENT & FUNDING SCENARIO
 
 
 
 
 
 
 
5.11
CASE STUDY ANALYSIS
 
 
 
 
 
 
5.12
IMPACT OF 2025 US TARIFFS—VETERINARY IMPLANT DEVICES MARKET
 
 
 
 
 
 
 
 
5.12.1
INTRODUCTION
 
 
 
 
 
 
5.12.2
KEY TARIFF RATES
 
 
 
 
 
 
5.12.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
 
5.12.4
IMPACT ON COUNTRIES/REGIONS
 
 
 
 
 
 
5.12.5
IMPACT ON END-USE INDUSTRIES
 
 
 
 
 
 
 
5.12.5.1
VETERINARY CLINICS & HOSPITALS
 
 
 
 
 
 
5.12.5.2
LIVESTOCK FARMS & PRODUCTION OPERATIONS
 
 
 
 
 
 
5.12.5.3
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS
 
 
 
 
 
 
5.12.5.4
VETERINARY RESEARCH INSTITUTIONS & ACADEMIC INSTITUTIONS
 
 
 
 
 
 
5.12.5.5
WILDLIFE & CONSERVATION ORGANIZATIONS
 
 
 
 
 
 
5.12.5.6
OTHER END USERS
 
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
AI-driven innovations redefine veterinary implants with personalized, wireless, and biosensing technologies for future applications.
 
 
 
 
 
98
 
6.1
KEY EMERGING TECHNOLOGIES
 
 
 
 
 
 
 
6.1.1
BIOABSORBABLE AND RESORBABLE IMPLANT MATERIALS
 
 
 
 
 
 
6.1.2
PATIENT-SPECIFIC AND 3D-PRINTED IMPLANTS
 
 
 
 
 
 
6.1.3
WIRELESSLY POWERED AND BATTERY-FREE ACTIVE IMPLANTS
 
 
 
 
 
6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
 
6.2.1
LONG-ACTING AND CONTROLLED-RELEASE DRUG DELIVERY PLATFORMS
 
 
 
 
 
 
6.2.2
ADVANCED IMPLANT COATINGS AND SURFACE MODIFICATION TECHNOLOGIES
 
 
 
 
 
6.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
 
6.3.1
IMPLANTABLE BIOSENSING AND CONTINUOUS DIAGNOSTICS
 
 
 
 
 
6.4
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
 
 
6.4.1
NEAR TERM (2026–2027)
 
 
 
 
 
 
6.4.2
MID-TERM (2028–2030)
 
 
 
 
 
 
6.4.3
LONG TERM (2031 AND BEYOND)
 
 
 
 
 
6.5
PATENT ANALYSIS
 
 
 
 
 
 
 
 
6.5.1
JURISDICTION & TOP APPLICANT ANALYSIS
 
 
 
 
 
6.6
FUTURE APPLICATIONS
 
 
 
 
 
 
 
6.6.1
CONTINUOUS PHYSIOLOGICAL MONITORING AND EARLY HEALTH ASSESSMENT
 
 
 
 
 
 
6.6.2
COMPLEX ORTHOPEDIC RECONSTRUCTION AND MOBILITY RESTORATION
 
 
 
 
 
 
6.6.3
SUSTAINED THERAPEUTIC MANAGEMENT
 
 
 
 
 
 
6.6.4
REPRODUCTIVE AND PRODUCTION PERFORMANCE MANAGEMENT
 
 
 
 
 
 
6.6.5
REMOTE ANIMAL HEALTH MONITORING
 
 
 
 
 
6.7
IMPACT OF AI/GENERATIVE AI ON VETERINARY IMPLANT DEVICES MARKET
 
 
 
 
 
 
 
 
6.7.1
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
 
 
6.7.2
BEST PRACTICES IN VETERINARY IMPLANT DEVICES MARKET
 
 
 
 
 
 
6.7.3
CASE STUDIES OF AI IMPLEMENTATION IN VETERINARY IMPLANT DEVICES MARKET
 
 
 
 
 
 
6.7.4
INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS IN VETERINARY IMPLANT DEVICES MARKET
 
 
 
 
 
 
6.7.5
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN THE VETERINARY IMPLANT DEVICES MARKET
 
 
 
 
 
6.8
HUMAN-LABELLED DEVICES ADOPTED OFF-LABEL IN VETERINARY PRACTICE (QUALITATIVE)
 
 
 
 
 
7
REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
Navigate complex global regulations with insights on sustainable practices in veterinary device manufacturing.
 
 
 
 
 
116
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
 
 
7.1.1
REGULATORY ANALYSIS
 
 
 
 
 
 
 
7.1.1.1
NORTH AMERICA
 
 
 
 
 
 
7.1.1.2
EUROPE
 
 
 
 
 
 
7.1.1.3
ASIA PACIFIC
 
 
 
 
 
7.1.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
7.2
INDUSTRY STANDARDS
 
 
 
 
 
 
 
7.2.1
BIOLOGICAL EVALUATION OF MEDICAL DEVICES STANDARD – ISO 10993-1:2025
 
 
 
 
 
 
7.2.2
LOCAL TISSUE RESPONSE AFTER IMPLANTATION STANDARD – ISO 10993-6:2026
 
 
 
 
 
 
7.2.3
ESSENTIAL PRINCIPLES FOR SURGICAL IMPLANTS STANDARD – ISO/TR 14283:2018
 
 
 
 
 
 
7.2.4
CLEANLINESS OF ORTHOPEDIC IMPLANTS STANDARD – ISO 19227:2018
 
 
 
 
 
 
7.2.5
CARE AND HANDLING OF ORTHOPEDIC IMPLANTS STANDARD – ASTM F565-26
 
 
 
 
 
 
7.2.6
PERMANENT MARKING OF ORTHOPEDIC IMPLANT COMPONENTS STANDARD – ASTM F983-24
 
 
 
 
 
 
7.2.7
BLOOD INTERACTION EVALUATION STANDARD – ISO 10993-4:2017
 
 
 
 
 
 
7.2.8
IN VITRO CYTOTOXICITY TESTING STANDARD – ISO 10993-5:2009
 
 
 
 
 
 
7.2.9
DEGRADATION PRODUCT EVALUATION STANDARD – ISO 10993-9:2019
 
 
 
 
 
7.3
REGULATION OF VETERINARY GROWTH-PROMOTANT AND HORMONE IMPLANTS BY REGION
 
 
 
 
 
 
 
7.3.1
NORTH AMERICA
 
 
 
 
 
 
7.3.2
EUROPE
 
 
 
 
 
 
7.3.3
ASIA PACIFIC
 
 
 
 
 
 
7.3.4
LATIN AMERICA
 
 
 
 
 
 
7.3.5
MIDDLE EAST & AFRICA
 
 
 
 
 
7.4
RULES AND RESTRICTIONS APPLYING TO RACING AND COMPETITION ANIMALS
 
 
 
 
 
 
 
7.4.1
NORTH AMERICA
 
 
 
 
 
 
7.4.2
EUROPE
 
 
 
 
 
 
7.4.3
ASIA PACIFIC
 
 
 
 
 
 
7.4.4
LATIN AMERICA
 
 
 
 
 
 
7.4.5
MIDDLE EAST & AFRICA
 
 
 
 
 
7.5
SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
 
7.5.1
REDUCING ENVIRONMENTAL IMPACT THROUGH VETERINARY DEVICE MANUFACTURING – ARTHREX/ARTHREX VET SYSTEMS
 
 
 
 
 
 
7.5.2
REDUCING ENVIRONMENTAL FOOTPRINT THROUGH SUSTAINABLE VETERINARY MEDTECH – MOVORA
 
 
 
 
 
 
7.5.3
SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
 
 
 
 
 
7.6
CERTIFICATIONS, LABELING, AND ECO-STANDARDS
 
 
 
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Unlock strategic insights into veterinary device adoption barriers and key buying influences.
 
 
 
 
 
130
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
 
 
8.2
KEY STAKEHOLDERS & BUYING CRITERIA
 
 
 
 
 
 
 
 
8.2.1
KEY STAKEHOLDERS
 
 
 
 
 
 
8.2.2
BUYING CRITERIA
 
 
 
 
 
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
 
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
 
 
 
8.5
MARKET PROFITABILITY
 
 
 
 
 
 
8.6
WILLINGNESS TO PAY: PET OWNERS, LIVESTOCK PRODUCERS, AND INSTITUTIONAL BUYERS
 
 
 
 
 
9
VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million and Units | 74 Data Tables
 
 
 
 
 
143
 
9.1
INTRODUCTION
 
 
 
 
 
 
9.2
ORTHOPEDIC & SKELETAL IMPLANTS
 
 
 
 
 
 
 
9.2.1
FRACTURE FIXATION PLATES, SCREWS, AND PINS
 
 
 
 
 
 
 
9.2.1.1
ADVANCEMENTS IN FIXATION SYSTEMS SUPPORTING FRACTURE MANAGEMENT
 
 
 
 
 
9.2.2
JOINT REPLACEMENT SYSTEMS
 
 
 
 
 
 
 
9.2.2.1
EXPANSION OF SPECIALIZED JOINT REPLACEMENT TECHNOLOGIES TO DRIVE MARKET
 
 
 
 
 
9.2.3
TPLO & TTA IMPLANTS
 
 
 
 
 
 
 
9.2.3.1
INCREASING DEMAND FOR ADVANCED STIFLE STABILIZATION IMPLANTS
 
 
 
 
 
9.2.4
OTHER ORTHOPEDIC & SKELETAL IMPLANTS
 
 
 
 
 
9.3
CARDIOVASCULAR & INTERVENTIONAL IMPLANTS
 
 
 
 
 
 
 
9.3.1
OCCLUDERS & CLOSURE DEVICES
 
 
 
 
 
 
 
9.3.1.1
GROWING ADOPTION OF MINIMALLY INVASIVE CARDIAC CLOSURE PROCEDURES
 
 
 
 
 
9.3.2
STENTS (TRACHEAL, BRONCHIAL, URETHERAL, VASCULAR)
 
 
 
 
 
 
 
9.3.2.1
INCREASING USE OF STENT-BASED INTERVENTIONS FOR STRUCTURAL AND OBSTRUCTIVE CONDITIONS
 
 
 
 
 
9.3.3
TRANSCATHETER VALVE REPAIR DEVICES
 
 
 
 
 
 
 
9.3.3.1
ADVANCEMENTS IN MINIMALLY INVASIVE TRANSCATHETER VALVE REPAIR
 
 
 
 
 
9.3.4
OTHER CARDIOVASCULAR & INTERVENTIONAL IMPLANTS
 
 
 
 
 
9.4
ACTIVE ELECTRONIC IMPLANTS
 
 
 
 
 
 
 
9.4.1
NEUROSTIMULATION IMPLANTS
 
 
 
 
 
 
 
9.4.1.1
UNMET NEED FOR ALTERNATIVE MANAGEMENT OF REFRACTORY NEUROLOGICAL DISORDERS
 
 
 
 
 
9.4.2
CARDIAC RHYTHM MANAGEMENT IMPLANTS
 
 
 
 
 
 
 
9.4.2.1
PACEMAKERS REMAIN AN ESTABLISHED INTERVENTION FOR SEVERE CONDUCTION ABNORMALITIES
 
 
 
 
 
9.4.3
OTHER ACTIVE ELECTRONIC IMPLANTS
 
 
 
 
 
9.5
URINARY & SOFT TISSUE IMPLANTS
 
 
 
 
 
 
 
9.5.1
SUBCUTANEOUS URETERAL BYPASS SYSTEMS
 
 
 
 
 
 
 
9.5.1.1
INCREASING USE OF LONG-TERM URINARY DIVERSION FOR URETERAL OBSTRUCTION IN CATS
 
 
 
 
 
9.5.2
ARTIFICIAL URETHRAL SPHINCTER SYSTEMS
 
 
 
 
 
 
 
9.5.2.1
GROWING APPLICATION OF ADJUSTABLE CONTINENCE IMPLANTS IN REFRACTORY URINARY INCONTINENCE
 
 
 
 
 
9.5.3
OTHER URINARY & SOFT TISSUE IMPLANTS
 
 
 
 
 
9.6
THERAPEUTIC & DRUG DELIVERY IMPLANTS
 
 
 
 
 
 
 
9.6.1
IMPLANTABLE DRUG DELIVERY DEVICES
 
 
 
 
 
 
 
9.6.1.1
ADVANCEMENTS IN CONTROLLED AND SUSTAINED DRUG RELEASE TECHNOLOGIES
 
 
 
 
 
9.6.2
REPRODUCTIVE & FERTILITY MANAGEMENT IMPLANTS
 
 
 
 
 
 
 
9.6.2.1
GROWING PREFERENCE FOR REVERSIBLE AND LONG-ACTING REPRODUCTIVE MANAGEMENT
 
 
 
 
 
9.6.3
GROWTH-PROMOTANT & PRODUCTION PERFORMANCE IMPLANTS
 
 
 
 
 
 
 
9.6.3.1
CONTINUED UTILIZATION OF HORMONAL IMPLANTS IN LIVESTOCK PRODUCTION
 
 
 
 
 
9.6.4
PAIN MANAGEMENT IMPLANTS
 
 
 
 
 
 
 
9.6.4.1
EMERGENCE OF EXTENDED-RELEASE APPROACHES FOR SUSTAINED ANALGESIC THERAPY
 
 
 
 
 
9.6.5
OTHER THERAPEUTIC & DRUG DELIVERY IMPLANTS
 
 
 
 
 
9.7
MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS
 
 
 
 
 
 
 
9.7.1
TEMPERATURE MONITORING IMPLANTS
 
 
 
 
 
 
 
9.7.1.1
GROWING USE OF CONTINUOUS CORE-TEMPERATURE MONITORING
 
 
 
 
 
9.7.2
VITAL SIGN MONITORING IMPLANTS
 
 
 
 
 
 
 
9.7.2.1
EXPANSION OF IMPLANTABLE PLATFORMS FOR CONTINUOUS CARDIORESPIRATORY MONITORING
 
 
 
 
 
9.7.3
ACTIVITY & MOTION SENSING IMPLANTS
 
 
 
 
 
 
 
9.7.3.1
INCREASING INTEGRATION OF MOTION TRACKING WITH PHYSIOLOGICAL MONITORING
 
 
 
 
 
9.7.4
IMPLANTABLE BIOSENSORS & DIAGNOSTIC IMPLANTS
 
 
 
 
 
 
 
9.7.4.1
PROGRESSION TOWARD MOLECULAR & REAL-TIME IN VIVO DIAGNOSTICS
 
 
 
 
 
9.7.5
INTRARUMINAL BOLUSES (INDWELLING MONITORING DEVICES)
 
 
 
 
 
 
 
9.7.5.1
INCREASING DEPLOYMENT OF SMART BOLUSES FOR LIVESTOCK HEALTH AND PRODUCTION MONITORING
 
 
 
 
 
9.7.6
OTHER MONITORING & SENSING IMPLANTS
 
 
 
 
 
9.8
OTHER IMPLANT DEVICES
 
 
 
 
 
10
VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 24 Data Tables
 
 
 
 
 
199
 
10.1
INTRODUCTION
 
 
 
 
 
 
10.2
COMPANION ANIMALS
 
 
 
 
 
 
 
10.2.1
DOGS
 
 
 
 
 
 
 
10.2.1.1
BROADENING USE OF ORTHOPEDIC AND PATIENT-SPECIFIC IMPLANTS IN CANINE SURGERY
 
 
 
 
 
10.2.2
CATS
 
 
 
 
 
 
 
10.2.2.1
INCREASING ADOPTION OF SPECIALIZED IMPLANTS FOR FELINE ORTHOPEDIC AND URINARY DISORDERS
 
 
 
 
 
10.2.3
OTHER COMPANION ANIMALS
 
 
 
 
 
10.3
PERFORMANCE & SPORTS ANIMALS
 
 
 
 
 
 
 
10.3.1
RACEHORSES
 
 
 
 
 
 
 
10.3.1.1
ADVANCED FIXATION SYSTEMS SUPPORT LIMB SALVAGE AND RETURN-TO-RACING POTENTIAL
 
 
 
 
 
10.3.2
SPORT & COMPETITION HORSES
 
 
 
 
 
 
 
10.3.2.1
INCREASING USE OF STENT-BASED INTERVENTIONS FOR STRUCTURAL AND OBSTRUCTIVE CONDITIONS
 
 
 
 
 
10.3.3
RACING CAMELS
 
 
 
 
 
 
 
10.3.3.1
SPECIALIZED SURGICAL CARE CREATES OPPORTUNITIES FOR CAMEL IMPLANT APPLICATIONS
 
 
 
 
 
10.3.4
HIGH-VALUE BREEDING CAMELS
 
 
 
 
 
 
 
10.3.4.1
REPRODUCTIVE AND FUNCTIONAL PRESERVATION STRENGTHEN DEMAND FOR SPECIALIZED INTERVENTIONS
 
 
 
 
 
10.3.5
WORKING DOGS
 
 
 
 
 
 
 
10.3.5.1
MUSCULOSKELETAL INJURY PREVENTION AND RECOVERY DRIVE IMPLANT USE IN WORKING DOGS
 
 
 
 
10.4
LIVESTOCK ANIMALS
 
 
 
 
 
 
 
10.4.1
CATTLE (DAIRY & BEEF)
 
 
 
 
 
 
 
10.4.1.1
ESTABLISHED PRODUCTION-PERFORMANCE APPLICATIONS SUSTAIN CATTLE IMPLANT DEMAND
 
 
 
 
 
10.4.2
SWINE
 
 
 
 
 
 
 
10.4.2.1
EMERGING IMPLANT-BASED DELIVERY TECHNOLOGIES EXPAND VETERINARY APPLICATIONS IN PIGS
 
 
 
 
 
10.4.3
SHEEP & GOATS
 
 
 
 
 
 
 
10.4.3.1
LONG-ACTING THERAPEUTIC AND REPRODUCTIVE IMPLANTS STRENGTHEN SMALL-RUMINANT APPLICATIONS
 
 
 
 
 
10.4.4
OTHER LIVESTOCK
 
 
 
 
 
10.5
WILDLIFE & CONSERVATION ANIMALS
 
 
 
 
 
 
 
10.5.1
DIFFICULTIES IN DIRECT OBSERVATION AND REPEATED CAPTURES NECESSITATE SPECIALIZED TREATMENTS
 
 
 
 
 
10.6
ZOO ANIMALS
 
 
 
 
 
 
 
10.6.1
HORMONAL IMPLANTS AND REPRODUCTIVE MANAGEMENT SEE STRONG DEMAND
 
 
 
 
 
10.7
RESEARCH ANIMALS
 
 
 
 
 
 
 
10.7.1
NEED FOR EVALUATING SURGICAL INTERVENTIONS AND IMPLANTS DRIVES MARKET
 
 
 
 
 
10.8
OTHER ANIMALS
 
 
 
 
 
11
VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 8 Data Tables
 
 
 
 
 
229
 
11.1
INTRODUCTION
 
 
 
 
 
 
11.2
ORTHOPEDIC & FRACTURE REPAIR
 
 
 
 
 
 
 
11.2.1
INCREASING ADOPTION OF ADVANCED FIXATION AND JOINT-RECONSTRUCTION PROCEDURES
 
 
 
 
 
11.3
CARDIOVASCULAR & INTERVENTIONAL TREATMENT
 
 
 
 
 
 
 
11.3.1
GROWING USE OF MINIMALLY INVASIVE CARDIOVASCULAR IMPLANT PROCEDURES
 
 
 
 
 
11.4
HEALTH & WELLNESS MONITORING
 
 
 
 
 
 
 
11.4.1
SHIFT TOWARD CONTINUOUS PHYSIOLOGICAL SURVEILLANCE
 
 
 
 
 
11.5
ACTIVITY, BEHAVIOR, AND PERFORMANCE MONITORING
 
 
 
 
 
 
 
11.5.1
INTEGRATION OF MOTION SENSING WITH ANIMAL PERFORMANCE ASSESSMENT
 
 
 
 
 
11.6
TREATMENT, DRUG DELIVERY, AND REPRODUCTIVE MANAGEMENT
 
 
 
 
 
 
 
11.6.1
EXPANSION OF LONG-ACTING IMPLANT-BASED THERAPEUTIC AND REPRODUCTIVE SOLUTIONS
 
 
 
 
 
11.7
PRODUCTION PERFORMANCE ENHANCEMENT
 
 
 
 
 
 
 
11.7.1
ESTABLISHED USE OF IMPLANT-BASED GROWTH AND FEED-EFFICIENCY MANAGEMENT
 
 
 
 
 
11.8
OTHER APPLICATIONS
 
 
 
 
 
12
VETERINARY IMPLANT DEVICES MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 7 Data Tables
 
 
 
 
 
241
 
12.1
INTRODUCTION
 
 
 
 
 
 
12.2
VETERINARY CLINICS & HOSPITALS
 
 
 
 
 
 
 
12.2.1
INCREASING ADOPTION OF SPECIALIZED IMPLANT-BASED VETERINARY PROCEDURES
 
 
 
 
 
12.3
LIVESTOCK FARMS & PRODUCTION OPERATIONS
 
 
 
 
 
 
 
12.3.1
GROWING USE OF IMPLANT-BASED REPRODUCTIVE, MONITORING, AND PRODUCTION SOLUTIONS
 
 
 
 
 
12.4
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS
 
 
 
 
 
 
 
12.4.1
INCREASING USE OF IMPLANTABLE DEVICES IN PRECLINICAL AND DRUG-DEVELOPMENT RESEARCH
 
 
 
 
 
12.5
VETERINARY RESEARCH INSTITUTES & ACADEMIC INSTITUTIONS
 
 
 
 
 
 
 
12.5.1
EXPANSION OF IMPLANT-BASED VETERINARY RESEARCH AND TRANSLATIONAL STUDIES
 
 
 
 
 
12.6
WILDLIFE & CONSERVATION ORGANIZATIONS
 
 
 
 
 
 
 
12.6.1
GROWING APPLICATION OF IMPLANT TECHNOLOGIES IN WILDLIFE MONITORING AND CONSERVATION
 
 
 
 
 
12.7
OTHER END USERS
 
 
 
 
 
13
VETERINARY IMPLANT DEVICES MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 17 Countries | 379 Data Tables.
 
 
 
 
 
252
 
13.1
INTRODUCTION
 
 
 
 
 
 
13.2
NORTH AMERICA
 
 
 
 
 
 
 
13.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
 
 
 
 
 
 
13.2.2
US
 
 
 
 
 
 
 
13.2.2.1
GROWTH IN SPECIALIZED VETERINARY CARE AND DIVERSIFIED ANIMAL-HEALTH APPLICATIONS
 
 
 
 
 
13.2.3
CANADA
 
 
 
 
 
 
 
13.2.3.1
EXPANSION OF LIVESTOCK SECTOR AND DEMAND FOR ADVANCED ANIMAL HEALTHCARE IN CANADA
 
 
 
 
13.3
EUROPE
 
 
 
 
 
 
 
13.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
 
 
 
 
 
 
13.3.2
GERMANY
 
 
 
 
 
 
 
13.3.2.1
STRONG VETERINARY INFRASTRUCTURE AND DEMAND FROM COMPANION & LIVESTOCK ANIMALS
 
 
 
 
 
13.3.3
UK
 
 
 
 
 
 
 
13.3.3.1
INCREASING ADOPTION OF PATIENT-SPECIFIC AND 3D-PRINTED VETERINARY IMPLANTS
 
 
 
 
 
13.3.4
FRANCE
 
 
 
 
 
 
 
13.3.4.1
EXPANSION OF SPECIALIZED VETERINARY SURGERY AND ORTHOPEDIC IMPLANT APPLICATIONS
 
 
 
 
 
13.3.5
ITALY
 
 
 
 
 
 
 
13.3.5.1
RISING PET CARE EXPENDITURE AND VETERINARY INFRASTRUCTURE INVESTMENT SUPPORTING MARKET GROWTH
 
 
 
 
 
13.3.6
SPAIN
 
 
 
 
 
 
 
13.3.6.1
GROWING ADOPTION OF VETERINARY CARDIAC IMPLANTS FOR AGE-RELATED HEART DISORDERS
 
 
 
 
 
13.3.7
REST OF EUROPE
 
 
 
 
 
13.4
ASIA PACIFIC
 
 
 
 
 
 
 
13.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
 
 
 
 
 
 
13.4.2
CHINA
 
 
 
 
 
 
 
13.4.2.1
CHINA TO WITNESS GROWING ADOPTION OF VETERINARY ORTHOPEDIC IMPLANTS DRIVEN BY ADVANCED MANUFACTURING, PERSONALIZED SURGERY, AND RISING DEMAND FOR SPECIALIZED PET HEALTHCARE
 
 
 
 
 
13.4.3
JAPAN
 
 
 
 
 
 
 
13.4.3.1
EXPANDING URINARY AND SOFT-TISSUE IMPLANT APPLICATIONS DRIVEN BY GOVERNMENT-FUNDED RESEARCH AND ADVANCED REGENERATIVE TECHNOLOGIES
 
 
 
 
 
13.4.4
INDIA
 
 
 
 
 
 
 
13.4.4.1
RISING DEMAND FOR VETERINARY JOINT-REPLACEMENT IMPLANTS AND GROWING PET HEALTHCARE SPENDING SUPPORTING MARKET GROWTH
 
 
 
 
 
13.4.5
AUSTRALIA
 
 
 
 
 
 
 
13.4.5.1
GROWING VETERINARY HEALTHCARE NEEDS AND TECHNOLOGICAL ADVANCEMENTS SUPPORTING MARKET GROWTH
 
 
 
 
 
13.4.6
SOUTH KOREA
 
 
 
 
 
 
 
13.4.6.1
HIGH GDP PER CAPITA AND GROWING ANIMAL HEALTHCARE INFRASTRUCTURE SUPPORT ADOPTION OF ADVANCED VETERINARY IMPLANT DEVICES
 
 
 
 
 
13.4.7
REST OF ASIA PACIFIC
 
 
 
 
 
13.5
LATIN AMERICA
 
 
 
 
 
 
 
13.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
 
 
 
 
 
 
13.5.2
BRAZIL
 
 
 
 
 
 
 
13.5.2.1
EXPANDING VETERINARY SURGICAL CAPABILITIES AND INDIGENOUS IMPLANT RESEARCH SUPPORTING MARKET GROWTH
 
 
 
 
 
13.5.3
MEXICO
 
 
 
 
 
 
 
13.5.3.1
LARGE LIVESTOCK ANIMAL POPULATION DRIVING DEMAND FOR VETERINARY IMPLANT DEVICES IN MEXICO
 
 
 
 
 
13.5.4
REST OF LATIN AMERICA
 
 
 
 
 
13.6
MIDDLE EAST & AFRICA
 
 
 
 
 
 
 
13.6.1
MACROECONOMIC OUTLOOK FOR THE MIDDLE EAST & AFRICA
 
 
 
 
 
 
13.6.2
GCC COUNTRIES
 
 
 
 
 
 
 
13.6.2.1
KINGDOM OF SAUDI ARABIA
 
 
 
 
 
 
 
 
13.6.2.1.1
LIVESTOCK HEALTHCARE INVESTMENT AND VETERINARY BIOTECHNOLOGY DEVELOPMENT TO DRIVE DEVICE ADOPTION
 
 
 
 
13.6.2.2
UAE
 
 
 
 
 
 
 
 
13.6.2.2.1
RISING COMPANION-ANIMAL HEALTHCARE SPENDING AND VETERINARY INFRASTRUCTURE DEVELOPMENT TO DRIVE MARKET
 
 
 
 
13.6.2.3
REST OF GCC COUNTRIES
 
 
 
 
 
13.6.3
REST OF MIDDLE EAST & AFRICA
 
 
 
 
14
COMPETITIVE LANDSCAPE
Key players dominate with strategic agility, reshaping the global veterinary implant market dynamics.
 
 
 
 
 
461
 
14.1
INTRODUCTION
 
 
 
 
 
 
14.2
KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2024–2026
 
 
 
 
 
 
 
14.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY IMPLANT DEVICES MARKET
 
 
 
 
 
14.3
REVENUE ANALYSIS, 2023–2025
 
 
 
 
 
 
 
14.4
MARKET SHARE ANALYSIS, 2025
 
 
 
 
 
 
 
 
14.4.1
GLOBAL VETERINARY IMPLANT DEVICES MARKET (2025)
 
 
 
 
 
 
14.4.2
US VETERINARY IMPLANT DEVICES MARKET (2025)
 
 
 
 
 
 
14.4.3
EUROPE VETERINARY IMPLANT DEVICES MARKET (2025)
 
 
 
 
 
14.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
 
 
 
 
 
 
 
 
14.5.1
VETERINARY IMPLANT DEVICES MARKET
 
 
 
 
 
 
 
14.5.1.1
STARS
 
 
 
 
 
 
14.5.1.2
EMERGING LEADERS
 
 
 
 
 
 
14.5.1.3
PERVASIVE PLAYERS
 
 
 
 
 
 
14.5.1.4
PARTICIPANTS
 
 
 
 
 
14.5.2
COMPANY FOOTPRINT: KEY PLAYERS, 2025
 
 
 
 
 
 
 
14.5.2.1
COMPANY FOOTPRINTS
 
 
 
 
 
 
14.5.2.2
REGION FOOTPRINT
 
 
 
 
 
 
14.5.2.3
IMPLANT DEVICE FOOTPRINT
 
 
 
 
 
 
14.5.2.4
APPLICATION FOOTPRINT
 
 
 
 
 
 
14.5.2.5
ANIMAL TYPE FOOTPRINT
 
 
 
 
14.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
 
14.6.1
PROGRESSIVE COMPANIES
 
 
 
 
 
 
14.6.2
RESPONSIVE COMPANIES
 
 
 
 
 
 
14.6.3
DYNAMIC COMPANIES
 
 
 
 
 
 
14.6.4
STARTING BLOCKS
 
 
 
 
 
 
14.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
14.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
 
14.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
14.7
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
 
 
 
14.7.1
FINANCIAL METRICS
 
 
 
 
 
 
14.7.2
COMPANY VALUATION
 
 
 
 
 
14.8
BRAND/PRODUCT COMPARISON
 
 
 
 
 
 
 
14.9
COMPETITIVE SCENARIO
 
 
 
 
 
 
 
14.9.1
PRODUCT LAUNCHES & APPROVALS
 
 
 
 
 
 
14.9.2
DEALS
 
 
 
 
 
 
14.9.3
EXPANSIONS
 
 
 
 
 
 
14.9.4
OTHER DEVELOPMENTS
 
 
 
 
15
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
 
 
487
 
15.1
KEY PLAYERS
 
 
 
 
 
 
 
15.1.1
MERCK & CO., INC.
 
 
 
 
 
 
 
15.1.1.1
BUSINESS OVERVIEW
 
 
 
 
 
 
15.1.1.2
PRODUCTS OFFERED
 
 
 
 
 
 
15.1.1.3
MNM VIEW
 
 
 
 
 
 
 
 
15.1.1.3.1
RIGHT TO WIN
 
 
 
 
 
 
15.1.1.3.2
STRATEGIC CHOICES
 
 
 
 
 
 
15.1.1.3.3
WEAKNESSES & COMPETITIVE THREATS
 
 
 
15.1.2
ZOETIS INC.
 
 
 
 
 
 
15.1.3
ELANCO
 
 
 
 
 
 
15.1.4
VIRBAC
 
 
 
 
 
 
15.1.5
JOHNSON & JOHNSON (DEPUY SYNTHES)
 
 
 
 
 
 
15.1.6
B. BRAUN SE
 
 
 
 
 
 
15.1.7
HARVARD BIOSCIENCE, INC. (DATA SCIENCES INTERNATIONAL)
 
 
 
 
 
 
15.1.8
SECUROS SURGICAL (CENCORA, INC.)
 
 
 
 
 
 
15.1.9
BIOMEDTRIX, LLC (MOVORA)
 
 
 
 
 
 
15.1.10
IMEX VETERINARY, INC. (MOVORA)
 
 
 
 
 
 
15.1.11
KYON (MOVORA)
 
 
 
 
 
 
15.1.12
NEW GENERATION DEVICES (NGD) (MOVORA)
 
 
 
 
 
 
15.1.13
VETERINARY ORTHOPEDIC IMPLANTS (VOI)(MOVORA)
 
 
 
 
 
 
15.1.14
ARTHREX, INC. (ARTHREX VET SYSTEMS)
 
 
 
 
 
 
15.1.15
INFINITI MEDICAL, LLC
 
 
 
 
 
15.2
OTHER PLAYERS
 
 
 
 
 
 
 
15.2.1
PUENHUA (CHANGZHOU) PET MEDICAL CO., LTD. (PURWOOF)
 
 
 
 
 
 
15.2.2
VETERINARY INSTRUMENTATION
 
 
 
 
 
 
15.2.3
STAR-ODDI
 
 
 
 
 
 
15.2.4
BIOTRONIK
 
 
 
 
 
 
15.2.5
THELMA BIOTEL
 
 
 
 
 
 
15.2.6
SMAXTEC ANIMAL CARE GMBH
 
 
 
 
 
 
15.2.7
AUXILIUM MD (TELIATRY, INC.)
 
 
 
 
 
 
15.2.8
BIOVETSENSOR
 
 
 
 
 
 
15.2.9
NORFOLK VET PRODUCTS
 
 
 
 
 
 
15.2.10
MISUZU INDUSTRIES CORPORATION
 
 
 
 
16
RESEARCH METHODOLOGY
 
 
 
 
 
555
 
16.1
RESEARCH DATA
 
 
 
 
 
 
 
16.1.1
SECONDARY DATA
 
 
 
 
 
 
 
16.1.1.1
KEY DATA FROM SECONDARY SOURCES
 
 
 
 
 
16.1.2
PRIMARY DATA
 
 
 
 
 
 
 
16.1.2.1
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
 
 
16.1.2.2
KEY PRIMARY PARTICIPANTS
 
 
 
 
 
 
16.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
 
 
 
 
 
 
16.1.2.4
KEY INDUSTRY INSIGHTS
 
 
 
 
16.2
MARKET SIZE ESTIMATION
 
 
 
 
 
 
 
16.2.1
APPROACH 1: COMPANY REVENUE ANALYSIS APPROACH
 
 
 
 
 
 
16.2.2
APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION
 
 
 
 
 
 
16.2.3
BOTTOM-UP APPROACH: SUPPLY-SIDE ANALYSIS
 
 
 
 
 
 
16.2.4
TOP-DOWN APPROACH
 
 
 
 
 
 
16.2.5
BASE NUMBER CALCULATION
 
 
 
 
 
 
 
16.2.5.1
COMPANY PRESENTATIONS
 
 
 
 
 
16.2.6
PRIMARY INTERVIEWS
 
 
 
 
 
 
16.2.7
VOLUME ESTIMATION
 
 
 
 
 
 
16.2.8
DEMAND-SIDE APPROACH
 
 
 
 
 
16.3
MARKET BREAKDOWN AND DATA TRIANGULATION
 
 
 
 
 
 
16.4
MARKET SHARE ASSESSMENT
 
 
 
 
 
 
16.5
RESEARCH ASSUMPTIONS
 
 
 
 
 
 
 
16.5.1
STUDY ASSUMPTIONS
 
 
 
 
 
 
16.5.2
GROWTH RATE ASSUMPTIONS
 
 
 
 
 
16.6
RISK ASSESSMENT
 
 
 
 
 
 
 
16.6.1
RESEARCH LIMITATIONS
 
 
 
 
17
APPENDIX
 
 
 
 
 
574
 
17.1
INSIGHTS OF INDUSTRY EXPERTS
 
 
 
 
 
 
 
17.1.1
VETERINARY BUSINESS MANAGER – ANIMAL HEALTH INDUSTRY, NORTH AMERICA
 
 
 
 
 
 
17.1.2
VETERINARY PRACTITIONER – COMPANION ANIMAL EXPERT, EUROPE
 
 
 
 
 
17.2
DISCUSSION GUIDE
 
 
 
 
 
 
17.3
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
 
17.4
AVAILABLE CUSTOMIZATION
 
 
 
 
 
 
 
17.4.1
GEOGRAPHIC ANALYSIS
 
 
 
 
 
 
17.4.2
REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS
 
 
 
 
 
 
17.4.3
COMPANY INFORMATION
 
 
 
 
 
 
17.4.4
COUNTRY-LEVEL VOLUME ANALYSIS
 
 
 
 
 
 
17.4.5
POWER SOURCE AND BATTERY ARCHITECTURE ANALYSIS FOR ACTIVE IMPLANTS
 
 
 
 
 
 
17.4.6
ANY CONSULTS/CUSTOM REQUIREMENTS AS PER CLIENT REQUEST
 
 
 
 
 
17.5
RELATED REPORTS
 
 
 
 
 
 
17.6
AUTHOR DETAILS
 
 
 
 
 
LIST OF TABLES
 
 
 
 
 
 
 
TABLE 1
VETERINARY IMPLANT DEVICES MARKET: INCLUSIONS & EXCLUSIONS
 
 
 
 
 
 
TABLE 2
STANDARD CURRENCY CONVERSION RATES
 
 
 
 
 
 
TABLE 3
GLOBAL RISE IN COMPANION ANIMAL POPULATION (MILLION) (2024 TO 2025)
 
 
 
 
 
 
TABLE 4
VETERINARY IMPLANT-BASED SURGERY COST (USD) (2025)
 
 
 
 
 
 
TABLE 5
VETERINARY IMPLANT DEVICES COST BY IMPLANT TYPE (USD) (2025)
 
 
 
 
 
 
TABLE 6
VETERINARY IMPLANT DEVICES: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
TABLE 7
GDP PER CAPITA, CURRENT PRICES BY KEY COUNTRY (2021–2031) (USD)
 
 
 
 
 
 
TABLE 8
AVERAGE SELLING PRICE TREND, BY IMPLANT DEVICE TYPE, 2023–2025 (USD)
 
 
 
 
 
 
TABLE 9
AVERAGE SELLING PRICE TREND OF IMPLANT DEVICES, BY REGION, 2023–2025 (USD)
 
 
 
 
 
 
TABLE 10
IMPORT DATA FOR HS CODE 9021, BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 11
EXPORT DATA FOR HS CODE 9021, BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 12
VETERINARY IMPLANT DEVICES MARKET: MAJOR CONFERENCES & EVENTS IN 2026–2027
 
 
 
 
 
 
TABLE 13
CASE STUDY 1: TPLO SURGERY USING JOHNSON & JOHNSON IMPLANTS (DEPUY SYNTHES)
 
 
 
 
 
 
TABLE 14
CASE STUDY 2: BRONCHIAL STENTING IN DOGS
 
 
 
 
 
 
TABLE 15
CASE STUDY 3: BILATERAL TOTAL HIP REPLACEMENT IN A DOG
 
 
 
 
 
 
TABLE 16
US ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
 
 
TABLE 17
NORTH AMERICA: IMPACT DUE TO THE US TARIFFS
 
 
 
 
 
 
TABLE 18
ASIA PACIFIC: IMPACT DUE TO THE US TARIFFS
 
 
 
 
 
 
TABLE 19
EUROPE: IMPACT DUE TO THE US TARIFFS
 
 
 
 
 
 
TABLE 20
VETERINARY IMPLANT DEVICES MARKET: MAJOR PATENTS
 
 
 
 
 
 
TABLE 21
KEY COMPANIES IMPLEMENTING AI IN VETERINARY IMPLANT DEVICES MARKET
 
 
 
 
 
 
TABLE 22
BEST PRACTICES IN VETERINARY IMPLANT DEVICES MARKET
 
 
 
 
 
 
TABLE 23
CASE STUDIES OF AI IMPLEMENTATION IN THE VETERINARY IMPLANT DEVICES MARKET
 
 
 
 
 
 
TABLE 24
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
 
 
TABLE 25
HUMAN-LABELED DEVICES ADOPTED OFF-LABEL IN VETERINARY PRACTICE
 
 
 
 
 
 
TABLE 26
NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 27
EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 28
ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 29
REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 30
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY IMPLANT DEVICES
 
 
 
 
 
 
TABLE 31
KEY BUYING CRITERIA FOR VETERINARY IMPLANT DEVICES, BY END USER
 
 
 
 
 
 
TABLE 32
ADOPTION BARRIERS AND INTERNAL CHALLENGES IN VETERINARY IMPLANT DEVICES MARKET
 
 
 
 
 
 
TABLE 33
UNMET NEEDS IN VETERINARY IMPLANT DEVICES FROM VARIOUS END USERS
 
 
 
 
 
 
TABLE 34
VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 35
IMPLANT DEVICES: VETERINARY IMPLANT DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 36
KEY PLAYERS PROVIDING ORTHOPEDIC & SKELETAL IMPLANTS
 
 
 
 
 
 
TABLE 37
VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 38
VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 39
KEY PLAYERS PROVIDING FRACTURE FIXATION PLATES, SCREWS, AND PINS
 
 
 
 
 
 
TABLE 40
FRACTURE FIXATION PLATES, SCREWS, AND PINS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 41
KEY PLAYERS PROVIDING JOINT REPLACEMENT SYSTEMS
 
 
 
 
 
 
TABLE 42
JOINT REPLACEMENT SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 43
KEY PLAYERS PROVIDING TPLO & TTA IMPLANTS
 
 
 
 
 
 
TABLE 44
TPLO & TTA IMPLANTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 45
KEY PLAYERS PROVIDING OTHER ORTHOPEDIC & SKELETAL IMPLANTS
 
 
 
 
 
 
TABLE 46
OTHER ORTHOPEDIC & SKELETAL IMPLANTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 47
KEY PLAYERS PROVIDING CARDIOVASCULAR & INTERVENTIONAL IMPLANTS
 
 
 
 
 
 
TABLE 48
VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 49
VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 50
KEY PLAYERS PROVIDING OCCLUDERS & CLOSURE DEVICES
 
 
 
 
 
 
TABLE 51
OCCLUDERS & CLOSURE DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 52
KEY PLAYERS PROVIDING STENTS (TRACHEAL, BRONCHIAL, URETHERAL, VASCULAR)
 
 
 
 
 
 
TABLE 53
STENTS (TRACHEAL, BRONCHIAL, URETHERAL, VASCULAR) MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 54
TRANSCATHETER VALVE REPAIR DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 55
KEY PLAYERS PROVIDING OTHER CARDIOVASCULAR & INTERVENTIONAL IMPLANTS
 
 
 
 
 
 
TABLE 56
OTHER CARDIOVASCULAR & INTERVENTIONAL IMPLANTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 57
KEY PLAYERS PROVIDING ACTIVE ELECTRONIC IMPLANTS
 
 
 
 
 
 
TABLE 58
VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 59
VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 60
KEY PLAYERS PROVIDING NEUROSTIMULATION IMPLANTS
 
 
 
 
 
 
TABLE 61
NEUROSTIMULATION IMPLANTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 62
KEY PLAYERS PROVIDING CARDIAC RHYTHM MANAGEMENT IMPLANTS
 
 
 
 
 
 
TABLE 63
CARDIAC RHYTHM MANAGEMENT IMPLANTS, BY REGION, BY VOLUME, 2024–2031 (MILLION UNITS)
 
 
 
 
 
 
TABLE 64
CARDIAC RHYTHM MANAGEMENT IMPLANTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 65
KEY PLAYERS PROVIDING OTHER ACTIVE ELECTRONIC IMPLANTS
 
 
 
 
 
 
TABLE 66
OTHER ACTIVE ELECTRONIC IMPLANTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 67
KEY PLAYERS PROVIDING URINARY & SOFT TISSUE IMPLANTS
 
 
 
 
 
 
TABLE 68
VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 69
VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 70
KEY PLAYERS PROVIDING SUBCUTANEOUS URETERAL BYPASS SYSTEMS
 
 
 
 
 
 
TABLE 71
SUBCUTANEOUS URETERAL BYPASS SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 72
KEY PLAYERS PROVIDING ARTIFICIAL URETHRAL SPHINCTER SYSTEMS
 
 
 
 
 
 
TABLE 73
ARTIFICIAL URETHRAL SPHINCTER SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 74
KEY PLAYERS PROVIDING OTHER URINARY & SOFT TISSUE IMPLANTS
 
 
 
 
 
 
TABLE 75
OTHER URINARY & SOFT TISSUE IMPLANTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)SS
 
 
 
 
 
 
TABLE 76
KEY PLAYERS PROVIDING THERAPEUTIC & DRUG DELIVERY IMPLANTS
 
 
 
 
 
 
TABLE 77
VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 78
VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 79
KEY PLAYERS PROVIDING IMPLANTABLE DRUG DELIVERY DEVICES
 
 
 
 
 
 
TABLE 80
IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 81
KEY PLAYERS PROVIDING REPRODUCTIVE & FERTILITY MANAGEMENT IMPLANTS
 
 
 
 
 
 
TABLE 82
REPRODUCTIVE & FERTILITY MANAGEMENT IMPLANTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 83
KEY PLAYERS PROVIDING GROWTH-PROMOTANT & PRODUCTION PERFORMANCE IMPLANTS
 
 
 
 
 
 
TABLE 84
GROWTH-PROMOTANT & PRODUCTION PERFORMANCE IMPLANTS,BY REGION, BY VOLUME, 2024–2031 (MILLION UNITS)
 
 
 
 
 
 
TABLE 85
GROWTH-PROMOTANT & PRODUCTION PERFORMANCE IMPLANTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 86
KEY PLAYERS PROVIDING PAIN MANAGEMENT IMPLANTS
 
 
 
 
 
 
TABLE 87
PAIN MANAGEMENT IMPLANTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 88
KEY PLAYERS PROVIDING OTHER THERAPEUTIC & DRUG DELIVERY IMPLANTS
 
 
 
 
 
 
TABLE 89
OTHER THERAPEUTIC & DRUG DELIVERY IMPLANTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 90
KEY PLAYERS PROVIDING MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS
 
 
 
 
 
 
TABLE 91
VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 92
VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 93
KEY PLAYERS PROVIDING TEMPERATURE MONITORING IMPLANTS
 
 
 
 
 
 
TABLE 94
TEMPERATURE MONITORING IMPLANTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 95
KEY PLAYERS PROVIDING VITAL SIGN MONITORING IMPLANTS
 
 
 
 
 
 
TABLE 96
VITAL SIGN MONITORING IMPLANTS,BY REGION, BY VOLUME, 2024–2031 (MILLION UNITS)
 
 
 
 
 
 
TABLE 97
VITAL SIGN MONITORING IMPLANTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 98
KEY PLAYERS PROVIDING ACTIVITY & MOTION SENSING IMPLANTS
 
 
 
 
 
 
TABLE 99
ACTIVITY & MOTION SENSING IMPLANTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 100
KEY PLAYERS PROVIDING IMPLANTABLE BIOSENSORS & DIAGNOSTIC IMPLANTS
 
 
 
 
 
 
TABLE 101
IMPLANTABLE BIOSENSORS & DIAGNOSTIC IMPLANTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 102
KEY PLAYERS PROVIDING INTRARUMINAL BOLUSES (INDWELLING MONITORING DEVICES)
 
 
 
 
 
 
TABLE 103
INTRARUMINAL BOLUSES (INDWELLING MONITORING DEVICES) MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 104
KEY PLAYERS PROVIDING OTHER MONITORING & SENSING IMPLANTS
 
 
 
 
 
 
TABLE 105
OTHER MONITORING & SENSING IMPLANTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 106
KEY PLAYERS PROVIDING OTHER IMPLANT DEVICES
 
 
 
 
 
 
TABLE 107
VETERINARY IMPLANT DEVICES MARKET FOR OTHER IMPLANT DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 108
VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 109
ANIMAL TYPE: VETERINARY IMPLANT DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 110
VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 111
VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 112
VETERINARY IMPLANT DEVICES MARKET FOR DOGS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 113
VETERINARY IMPLANT DEVICES MARKET FOR CATS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 114
VETERINARY IMPLANT DEVICES MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 115
VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 116
VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 117
VETERINARY IMPLANT DEVICES MARKET FOR RACEHORSES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 118
VETERINARY IMPLANT DEVICES MARKET FOR SPORT & COMPETITION HORSES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 119
VETERINARY IMPLANT DEVICES MARKET FOR RACING CAMELS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 120
VETERINARY IMPLANT DEVICES MARKET FOR HIGH-VALUE BREEDING CAMELS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 121
VETERINARY IMPLANT DEVICES MARKET FOR WORKING DOGS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 122
VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 123
VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 124
VETERINARY IMPLANT DEVICES MARKET FOR CATTLE (DAIRY & BEEF), BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 125
VETERINARY IMPLANT DEVICES MARKET FOR SWINE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 126
VETERINARY IMPLANT DEVICES MARKET FOR SHEEP & GOATS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 127
VETERINARY IMPLANT DEVICES MARKET FOR OTHER LIVESTOCK, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 128
VETERINARY IMPLANT DEVICES MARKET FOR WILDLIFE & CONSERVATION ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 129
VETERINARY IMPLANT DEVICES MARKET FOR ZOO ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 130
VETERINARY IMPLANT DEVICES MARKET FOR RESEARCH ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 131
VETERINARY IMPLANT DEVICES MARKET FOR OTHER ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 132
VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 133
VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & FRACTURE REPAIR, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 134
VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL TREATMENT, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 135
VETERINARY IMPLANT DEVICES MARKET FOR HEALTH & WELLNESS MONITORING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 136
VETERINARY IMPLANT DEVICES MARKET FOR ACTIVITY, BEHAVIOR, AND PERFORMANCE MONITORING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 137
VETERINARY IMPLANT DEVICES MARKET FOR TREATMENT, DRUG DELIVERY, AND REPRODUCTIVE MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 138
VETERINARY IMPLANT DEVICES MARKET FOR PRODUCTION PERFORMANCE ENHANCEMENT, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 139
VETERINARY IMPLANT DEVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 140
VETERINARY IMPLANT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 141
VETERINARY IMPLANT DEVICES MARKET FOR VETERINARY CLINICS & HOSPITALS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 142
VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK FARMS & PRODUCTION OPERATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 143
VETERINARY IMPLANT DEVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 144
VETERINARY IMPLANT DEVICES MARKET FOR VETERINARY RESEARCH INSTITUTES & ACADEMIC INSTITUTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 145
VETERINARY IMPLANT DEVICES MARKET FOR WILDLIFE & CONSERVATION ORGANIZATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 146
VETERINARY IMPLANT DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 147
VETERINARY IMPLANT DEVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 148
NORTH AMERICA: VETERINARY IMPLANT DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 149
NORTH AMERICA: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 150
NORTH AMERICA: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, BY VOLUME, 2024–2031 (MILLION UNITS)
 
 
 
 
 
 
TABLE 151
NORTH AMERICA: VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 152
NORTH AMERICA: VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 153
NORTH AMERICA: VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 154
NORTH AMERICA: VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 155
NORTH AMERICA: VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 156
NORTH AMERICA: VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 157
NORTH AMERICA: VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 158
NORTH AMERICA: VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 159
NORTH AMERICA: VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 160
NORTH AMERICA: VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 161
NORTH AMERICA: VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 162
NORTH AMERICA: VETERINARY IMPLANT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 163
US: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 164
US: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 165
US: VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 166
US: VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 167
US: VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 168
US: VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 169
US: VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 170
US: VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 171
US: VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 172
US: VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 173
US: VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 174
US: VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 175
US: VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 176
US: VETERINARY IMPLANT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 177
CANADA: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 178
CANADA: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 179
CANADA: VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 180
CANADA: VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 181
CANADA: VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 182
CANADA: VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 183
CANADA: VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 184
CANADA: VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 185
CANADA: VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 186
CANADA: VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 187
CANADA: VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 188
CANADA: VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 189
CANADA: VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 190
CANADA: VETERINARY IMPLANT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 191
EUROPE: VETERINARY IMPLANT DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 192
EUROPE: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 193
EUROPE: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, BY VOLUME, 2024–2031 (MILLION UNITS)
 
 
 
 
 
 
TABLE 194
EUROPE: VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 195
EUROPE: VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 196
EUROPE: VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 197
EUROPE: VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 198
EUROPE: VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 199
EUROPE: VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 200
EUROPE: VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 201
EUROPE: VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 202
EUROPE: VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 203
EUROPE: VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 204
EUROPE: VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 205
EUROPE: VETERINARY IMPLANT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 206
GERMANY: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 207
GERMANY: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 208
GERMANY: VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 209
GERMANY: VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 210
GERMANY: VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 211
GERMANY: VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 212
GERMANY: VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 213
GERMANY: VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 214
GERMANY: VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 215
GERMANY: VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 216
GERMANY: VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 217
GERMANY: VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 218
GERMANY: VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 219
GERMANY: VETERINARY IMPLANT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 220
UK: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 221
UK: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 222
UK: VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 223
UK: VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 224
UK: VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 225
UK: VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 226
UK: VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 227
UK: VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 228
UK: VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 229
UK: VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 230
UK: VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 231
UK: VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 232
UK: VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 233
UK: VETERINARY IMPLANT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 234
FRANCE: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 235
FRANCE: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 236
FRANCE: VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 237
FRANCE: VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 238
FRANCE: VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 239
FRANCE: VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 240
FRANCE: VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 241
FRANCE: VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 242
FRANCE: VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 243
FRANCE: VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 244
FRANCE: VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 245
FRANCE: VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 246
FRANCE: VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 247
FRANCE: VETERINARY IMPLANT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 248
ITALY: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 249
ITALY: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 250
ITALY: VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 251
ITALY: VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 252
ITALY: VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 253
ITALY: VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 254
ITALY: VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 255
ITALY: VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 256
ITALY: VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 257
ITALY: VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 258
ITALY: VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 259
ITALY: VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 260
ITALY: VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 261
ITALY: VETERINARY IMPLANT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 262
SPAIN: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 263
SPAIN: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 264
SPAIN: VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 265
SPAIN: VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 266
SPAIN: VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 267
SPAIN: VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 268
SPAIN: VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 269
SPAIN: VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 270
SPAIN: VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 271
SPAIN: VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 272
SPAIN: VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 273
SPAIN: VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 274
SPAIN: VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 275
SPAIN: VETERINARY IMPLANT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 276
REST OF EUROPE: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 277
REST OF EUROPE: VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 278
REST OF EUROPE: VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 279
REST OF EUROPE: VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 280
REST OF EUROPE: VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 281
REST OF EUROPE: VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 282
REST OF EUROPE: VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 283
REST OF EUROPE: VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 284
REST OF EUROPE: VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 285
REST OF EUROPE: VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 286
REST OF EUROPE: VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 287
REST OF EUROPE: VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 288
REST OF EUROPE: VETERINARY IMPLANT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 289
ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 290
ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 291
ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, BY VOLUME, 2024–2031 (MILLION UNITS)
 
 
 
 
 
 
TABLE 292
ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 293
ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 294
ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 295
ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 296
ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 297
ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 298
ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 299
ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 300
ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 301
ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 302
ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 303
ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 304
CHINA: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 305
CHINA: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 306
CHINA: VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 307
CHINA: VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 308
CHINA: VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 309
CHINA: VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 310
CHINA: VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 311
CHINA: VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 312
CHINA: VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 313
CHINA: VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 314
CHINA: VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 315
CHINA: VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 316
CHINA: VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 317
CHINA: VETERINARY IMPLANT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 318
JAPAN: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 319
JAPAN: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 320
JAPAN: VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 321
JAPAN: VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 322
JAPAN: VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 323
JAPAN: VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 324
JAPAN: VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 325
JAPAN: VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 326
JAPAN: VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 327
JAPAN: VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 328
JAPAN: VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 329
JAPAN: VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 330
JAPAN: VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 331
JAPAN: VETERINARY IMPLANT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 332
INDIA: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 333
INDIA: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 334
INDIA: VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 335
INDIA: VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 336
INDIA: VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 337
INDIA: VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 338
INDIA: VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 339
INDIA: VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 340
INDIA: VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 341
INDIA: VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 342
INDIA: VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 343
INDIA: VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 344
INDIA: VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 345
INDIA: VETERINARY IMPLANT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 346
AUSTRALIA: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 347
AUSTRALIA: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 348
AUSTRALIA: VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 349
AUSTRALIA: VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 350
AUSTRALIA: VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 351
AUSTRALIA: VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 352
AUSTRALIA: VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 353
AUSTRALIA: VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 354
AUSTRALIA: VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 355
AUSTRALIA: VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 356
AUSTRALIA: VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 357
AUSTRALIA: VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 358
AUSTRALIA: VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 359
AUSTRALIA: VETERINARY IMPLANT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 360
SOUTH KOREA: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 361
SOUTH KOREA: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 362
SOUTH KOREA: VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 363
SOUTH KOREA: VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 364
SOUTH KOREA: VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 365
SOUTH KOREA: VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 366
SOUTH KOREA: VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 367
SOUTH KOREA: VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 368
SOUTH KOREA: VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 369
SOUTH KOREA: VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 370
SOUTH KOREA: VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 371
SOUTH KOREA: VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 372
SOUTH KOREA: VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 373
SOUTH KOREA: VETERINARY IMPLANT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 374
REST OF ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 375
REST OF ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 376
REST OF ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 377
REST OF ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 378
REST OF ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 379
REST OF ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 380
REST OF ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 381
REST OF ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 382
REST OF ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 383
REST OF ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 384
REST OF ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 385
REST OF ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 386
REST OF ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 387
LATIN AMERICA: VETERINARY IMPLANT DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 388
LATIN AMERICA: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 389
LATIN AMERICA: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE BY VOLUME, 2024–2031 (MILLION UNITS)
 
 
 
 
 
 
TABLE 390
LATIN AMERICA: VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 391
LATIN AMERICA: VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 392
LATIN AMERICA: VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 393
LATIN AMERICA: VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 394
LATIN AMERICA: VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 395
LATIN AMERICA: VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 396
LATIN AMERICA: VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 397
LATIN AMERICA: VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 398
LATIN AMERICA: VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 399
LATIN AMERICA: VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 400
LATIN AMERICA: VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 401
LATIN AMERICA: VETERINARY IMPLANT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 402
BRAZIL: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 403
BRAZIL: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 404
BRAZIL: VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 405
BRAZIL: VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 406
BRAZIL: VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 407
BRAZIL: VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 408
BRAZIL: VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 409
BRAZIL: VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 410
BRAZIL: VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 411
BRAZIL: VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 412
BRAZIL: VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 413
BRAZIL: VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 414
BRAZIL: VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 415
BRAZIL: VETERINARY IMPLANT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 416
MEXICO: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 417
MEXICO: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 418
MEXICO: VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 419
MEXICO: VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 420
MEXICO: VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 421
MEXICO: VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 422
MEXICO: VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 423
MEXICO: VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 424
MEXICO: VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 425
MEXICO: VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 426
MEXICO: VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 427
MEXICO: VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 428
MEXICO: VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 429
MEXICO: VETERINARY IMPLANT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 430
REST OF LATIN AMERICA: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 431
REST OF LATIN AMERICA: VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 432
REST OF LATIN AMERICA: VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 433
REST OF LATIN AMERICA: VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 434
REST OF LATIN AMERICA: VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 435
REST OF LATIN AMERICA: VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 436
REST OF LATIN AMERICA: VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 437
REST OF LATIN AMERICA: VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 438
REST OF LATIN AMERICA: VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 439
REST OF LATIN AMERICA: VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 440
REST OF LATIN AMERICA: VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 441
REST OF LATIN AMERICA: VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 442
REST OF LATIN AMERICA: VETERINARY IMPLANT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 443
MIDDLE EAST & AFRICA: VETERINARY IMPLANT DEVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 444
MIDDLE EAST & AFRICA: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 445
MIDDLE EAST & AFRICA: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, BY VOLUME, 2024–2031 (MILLION UNITS)
 
 
 
 
 
 
TABLE 446
MIDDLE EAST & AFRICA: VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 447
MIDDLE EAST & AFRICA: VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 448
MIDDLE EAST & AFRICA: VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 449
MIDDLE EAST & AFRICA: VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 450
MIDDLE EAST & AFRICA: VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 451
MIDDLE EAST & AFRICA: VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 452
MIDDLE EAST & AFRICA: VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 453
MIDDLE EAST & AFRICA: VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 454
MIDDLE EAST & AFRICA: VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 455
MIDDLE EAST & AFRICA: VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 456
MIDDLE EAST & AFRICA: VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 457
MIDDLE EAST & AFRICA: VETERINARY IMPLANT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 458
GCC COUNTRIES: VETERINARY IMPLANT DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 459
GCC COUNTRIES: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 460
GCC COUNTRIES: VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 461
GCC COUNTRIES: VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 462
GCC COUNTRIES: VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 463
GCC COUNTRIES: VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 464
GCC COUNTRIES: VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 465
GCC COUNTRIES: VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 466
GCC COUNTRIES: VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 467
GCC COUNTRIES: VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 468
GCC COUNTRIES: VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 469
GCC COUNTRIES: VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 470
GCC COUNTRIES: VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 471
GCC COUNTRIES: VETERINARY IMPLANT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 472
KINGDOM OF SAUDI ARABIA: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 473
KINGDOM OF SAUDI ARABIA: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 474
KINGDOM OF SAUDI ARABIA: VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 475
KINGDOM OF SAUDI ARABIA: VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 476
KINGDOM OF SAUDI ARABIA: VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 477
KINGDOM OF SAUDI ARABIA: VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 478
KINGDOM OF SAUDI ARABIA: VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 479
KINGDOM OF SAUDI ARABIA: VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 480
KINGDOM OF SAUDI ARABIA: VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 481
KINGDOM OF SAUDI ARABIA: VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 482
KINGDOM OF SAUDI ARABIA: VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 483
KINGDOM OF SAUDI ARABIA: VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 484
KINGDOM OF SAUDI ARABIA: VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 485
KINGDOM OF SAUDI ARABIA: VETERINARY IMPLANT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 486
UAE: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 487
UAE: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 488
UAE: VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 489
UAE: VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 490
UAE: VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 491
UAE: VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 492
UAE: VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 493
UAE: VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 494
UAE: VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 495
UAE: VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 496
UAE: VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 497
UNITED ARAB EMIRATES: VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 498
UAE: VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 499
UAE: VETERINARY IMPLANT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 500
REST OF GCC COUNTRIES: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 501
REST OF GCC COUNTRIES: VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 502
REST OF GCC COUNTRIES: VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 503
REST OF GCC COUNTRIES: VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 504
REST OF GCC COUNTRIES: VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 505
REST OF GCC COUNTRIES: VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 506
REST OF GCC COUNTRIES: VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 507
REST OF GCC COUNTRIES: VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 508
REST OF GCC COUNTRIES: VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 509
REST OF GCC COUNTRIES: VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 510
REST OF GCC COUNTRIES: VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 511
REST OF GCC COUNTRIES: VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 512
REST OF GCC COUNTRIES: VETERINARY IMPLANT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 513
REST OF MIDDLE EAST & AFRICA: VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 514
REST OF MIDDLE EAST & AFRICA: VETERINARY IMPLANT DEVICES MARKET FOR ORTHOPEDIC & SKELETAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 515
REST OF MIDDLE EAST & AFRICA: VETERINARY IMPLANT DEVICES MARKET FOR CARDIOVASCULAR & INTERVENTIONAL IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 516
REST OF MIDDLE EAST & AFRICA: VETERINARY IMPLANT DEVICES MARKET FOR ACTIVE ELECTRONIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 517
REST OF MIDDLE EAST & AFRICA: VETERINARY IMPLANT DEVICES MARKET FOR URINARY & SOFT TISSUE IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 518
REST OF MIDDLE EAST & AFRICA: VETERINARY IMPLANT DEVICES MARKET FOR THERAPEUTIC & DRUG DELIVERY IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 519
REST OF MIDDLE EAST & AFRICA: VETERINARY IMPLANT DEVICES MARKET FOR MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 520
REST OF MIDDLE EAST & AFRICA: VETERINARY IMPLANT DEVICES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 521
REST OF MIDDLE EAST & AFRICA: VETERINARY IMPLANT DEVICES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 522
REST OF MIDDLE EAST & AFRICA: VETERINARY IMPLANT DEVICES MARKET FOR PERFORMANCE & SPORTS ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 523
REST OF MIDDLE EAST & AFRICA: VETERINARY IMPLANT DEVICES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 524
REST OF MIDDLE EAST & AFRICA: VETERINARY IMPLANT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 525
REST OF MIDDLE EAST & AFRICA: VETERINARY IMPLANT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 526
OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN VETERINARY IMPLANT DEVICES MARKET, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 527
GLOBAL VETERINARY IMPLANT DEVICES MARKET: DEGREE OF COMPETITION
 
 
 
 
 
 
TABLE 528
US VETERINARY IMPLANT DEVICES MARKET: DEGREE OF COMPETITION
 
 
 
 
 
 
TABLE 529
EUROPE VETERINARY IMPLANT DEVICES MARKET: DEGREE OF COMPETITION
 
 
 
 
 
 
TABLE 530
VETERINARY IMPLANT DEVICES MARKET: REGION FOOTPRINT
 
 
 
 
 
 
TABLE 531
VETERINARY IMPLANT DEVICES MARKET: IMPLANT DEVICE FOOTPRINT
 
 
 
 
 
 
TABLE 532
VETERINARY IMPLANT DEVICES MARKET: APPLICATION FOOTPRINT
 
 
 
 
 
 
TABLE 533
VETERINARY IMPLANT DEVICES MARKET: ANIMAL TYPE FOOTPRINT
 
 
 
 
 
 
TABLE 534
VETERINARY IMPLANT DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
 
TABLE 535
VETERINARY IMPLANT DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SME PLAYERS
 
 
 
 
 
 
TABLE 536
VETERINARY IMPLANT DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 537
VETERINARY IMPLANT DEVICES MARKET: DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 538
VETERINARY IMPLANT DEVICES MARKET: EXPANSIONS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 539
VETERINARY IMPLANT DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 540
MERCK & CO., INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 541
MERCK & CO., INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 542
ZOETIS INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 543
ZOETIS INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 544
ZOETIS INC.: PRODUCT LAUNCHES, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 545
ELANCO: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 546
ELANCO: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 547
ELANCO: OTHER DEVELOPMENTS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 548
VIRBAC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 549
VIRBAC: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 550
VIRBAC: PRODUCT APPROVALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 551
VIRBAC: EXPANSIONS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 552
VIRBAC: OTHER DEVELOPMENTS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 553
JOHNSON & JOHNSON (DEPUY SYNTHES): COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 554
JOHNSON & JOHNSON (DEPUY SYNTHES): PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 555
B. BRAUN SE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 556
B. BRAUN SE: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 557
HARVARD BIOSCIENCE, INC. (DATA SCIENCES INTERNATIONAL): COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 558
HARVARD BIOSCIENCE, INC. (DATA SCIENCES INTERNATIONAL): PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 559
HARVARD BIOSCIENCE, INC. (DATA SCIENCES INTERNATIONAL): PRODUCT UPGRADES, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 560
HARVARD BIOSCIENCE, INC. (DATA SCIENCES INTERNATIONAL): OTHER DEVELOPMENTS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 561
SECUROS SURGICAL (CENCORA, INC.): COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 562
SECUROS SURGICAL (CENCORA, INC.): PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 563
SECUROS SURGICAL (CENCORA, INC.): DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 564
SECUROS SURGICAL (CENCORA, INC.): OTHER DEVELOPMENTS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 565
BIOMEDTRIX, LLC (MOVORA): COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 566
BIOMEDTRIX, LLC (MOVORA): PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 567
BIOMEDTRIX, LLC (MOVORA): DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 568
IMEX VETERINARY, INC. (MOVORA): COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 569
IMEX VETERINARY, INC. (MOVORA): PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 570
IMEX VETERINARY IMPLANTS: OTHER DEVELOPMENTS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 571
KYON (MOVORA): COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 572
KYON (MOVORA): PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 573
KYON (MOVORA): OTHER DEVELOPMENTS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 574
NEW GENERATION DEVICES (NGD) (MOVORA): COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 575
NEW GENERATION DEVICES (NGD): PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 576
NEW GENERATION DEVICES: DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 577
VETERINARY ORTHOPEDIC IMPLANTS (VOI) (MOVORA): COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 578
VETERINARY ORTHOPEDIC IMPLANTS (VOI) (MOVORA): PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 579
VETERINARY ORTHOPEDIC IMPLANTS (VOI) (MOVORA): DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 580
ARTHREX, INC. (ARTHREX VET SYSTEMS): COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 581
ARTHREX, INC. (ARTHREX VET SYSTEMS): PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 582
ARTHREX, INC. (ARTHREX VET SYSTEMS): PRODUCT LAUNCHES, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 583
ARTHREX, INC. (ARTHREX VET SYSTEMS): OTHER DEVELOPMENTS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 584
INFINITI MEDICAL, LLC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 585
INFINITI MEDICAL, LLC: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 586
INFINITI MEDICAL, LLC: PRODUCT ENHANCEMENTS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 587
INFINITI MEDICAL, LLC: OTHER DEVELOPMENTS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 588
STUDY ASSUMPTIONS
 
 
 
 
 
 
TABLE 589
VETERINARY IMPLANT DEVICES MARKET: RISK ASSESSMENT ANALYSIS
 
 
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
 
 
FIGURE 1
VETERINARY IMPLANT DEVICES MARKET: SEGMENTS CONSIDERED
 
 
 
 
 
 
FIGURE 2
REGIONAL SCOPE
 
 
 
 
 
 
FIGURE 3
MARKET SCENARIO
 
 
 
 
 
 
FIGURE 4
GLOBAL VETERINARY IMPLANT DEVICES MARKET, 2024–2031
 
 
 
 
 
 
FIGURE 5
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN THE VETERINARY IMPLANT DEVICES MARKET, 2024–2026
 
 
 
 
 
 
FIGURE 6
DISRUPTIONS INFLUENCING GROWTH OF VETERINARY IMPLANT DEVICES MARKET
 
 
 
 
 
 
FIGURE 7
HIGH-GROWTH SEGMENTS IN VETERINARY IMPLANT DEVICES MARKET, 2026–2031
 
 
 
 
 
 
FIGURE 8
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN VETERINARY IMPLANT DEVICES MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 9
INCREASING PREVALENCE OF DISEASES AND ADOPTION OF VETERINARY SURGICAL PROCEDURES TO DRIVE MARKET GROWTH
 
 
 
 
 
 
FIGURE 10
ORTHOPEDIC & SKELETAL IMPLANTS SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2025
 
 
 
 
 
 
FIGURE 11
INDIA TO WITNESS THE HIGHEST CAGR DURING THE FORECAST PERIOD
 
 
 
 
 
 
FIGURE 12
VETERINARY IMPLANT DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
 
 
FIGURE 13
VETERINARY IMPLANT DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
 
 
 
 
 
 
FIGURE 14
VETERINARY IMPLANT DEVICES MARKET: SUPPLY CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 15
VETERINARY IMPLANT DEVICES MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 16
VETERINARY IMPLANT DEVICES MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
 
 
FIGURE 17
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
 
 
FIGURE 18
INVESTMENT & FUNDING SCENARIO (2023–2026)
 
 
 
 
 
 
FIGURE 19
VETERINARY IMPLANT DEVICES MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2016–AUGUST 2026)
 
 
 
 
 
 
FIGURE 20
TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY IMPLANT DEVICE PATENTS (JANUARY 2016–AUGUST 2026)
 
 
 
 
 
 
FIGURE 21
KEY FEATURES OF AI/GENERATIVE AI IN THE VETERINARY IMPLANT DEVICES MARKET
 
 
 
 
 
 
FIGURE 22
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY IMPLANT DEVICES
 
 
 
 
 
 
FIGURE 23
KEY BUYING CRITERIA FOR VETERINARY IMPLANT DEVICES, BY END USER
 
 
 
 
 
 
FIGURE 24
NORTH AMERICA: VETERINARY IMPLANT DEVICES MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 25
ASIA PACIFIC: VETERINARY IMPLANT DEVICES MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 26
REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY IMPLANT DEVICES MARKET, 2023–2025
 
 
 
 
 
 
FIGURE 27
GLOBAL MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
 
 
 
 
 
 
FIGURE 28
US MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
 
 
 
 
 
 
FIGURE 29
EUROPE MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
 
 
 
 
 
 
FIGURE 30
VETERINARY IMPLANT DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
 
 
 
 
 
 
FIGURE 31
VETERINARY IMPLANT DEVICES MARKET: COMPANY FOOTPRINT
 
 
 
 
 
 
FIGURE 32
VETERINARY IMPLANT DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
 
 
 
 
 
 
FIGURE 33
EV/EBITDA OF KEY VENDORS FOR THE VETERINARY IMPLANT DEVICES MARKET
 
 
 
 
 
 
FIGURE 34
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS FOR THE VETERINARY IMPLANT DEVICES MARKET
 
 
 
 
 
 
FIGURE 35
VETERINARY IMPLANT DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
 
 
 
 
 
 
FIGURE 36
MERCK & CO., INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 37
ZOETIS INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 38
ELANCO: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 39
VIRBAC: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 40
JOHNSON & JOHNSON (DEPUY SYNTHES): COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 41
B. BRAUN SE: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 42
HARVARD BIOSCIENCE, INC. (DATA SCIENCES INTERNATIONAL): COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 43
VETERINARY IMPLANT DEVICES MARKET: RESEARCH DESIGN
 
 
 
 
 
 
FIGURE 44
PRIMARY SOURCES
 
 
 
 
 
 
FIGURE 45
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
 
 
 
 
 
 
FIGURE 46
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
 
 
 
 
 
 
FIGURE 47
BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS
 
 
 
 
 
 
FIGURE 48
RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
 
 
 
 
 
 
FIGURE 49
MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
 
 
 
 
 
 
FIGURE 50
REVENUE SHARE ANALYSIS ILLUSTRATION: MERCK & CO., INC (2025)
 
 
 
 
 
 
FIGURE 51
BOTTOM-UP APPROACH
 
 
 
 
 
 
FIGURE 52
TOP-DOWN APPROACH
 
 
 
 
 
 
FIGURE 53
SUPPLY-SIDE ANALYSIS: VETERINARY IMPLANT DEVICES MARKET (2025)
 
 
 
 
 
 
FIGURE 54
DEMAND-SIDE APPROACH
 
 
 
 
 
 
FIGURE 55
VETERINARY IMPLANT DEVICES MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2026–2031)
 
 
 
 
 
 
FIGURE 56
CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
 
 
 
 
 
 
FIGURE 57
MARKET DATA TRIANGULATION METHODOLOGY
 
 
 
 
 
 

Methodology

This study involved four major activities in estimating the size of the veterinary implant devices market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research. The bottom-up approach was employed to estimate the overall market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.

Secondary Research

The secondary research process involved the widespread use of secondary sources, directories, databases (Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the veterinary implant devices market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, product managers, R&D and regulatory affairs heads, and business development managers from companies manufacturing veterinary orthopedic, cardiovascular, drug delivery, and monitoring implants, as well as distributors of veterinary surgical products. The primary sources from the demand side include board-certified veterinary surgeons, veterinary cardiologists, hospital and practice owners, procurement and purchase managers of veterinary hospital groups, livestock veterinarians and farm managers, researchers at veterinary schools and contract research organizations, and wildlife and zoo veterinarians. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.

A breakdown of the primary respondents is provided below:

Veterinary Implant Devices Market Size, and Share

*C-level primaries include CEOs, CFOs, COOs, and VPs.
*Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Source: MarketsandMarkets Analysis

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The research methodology used to estimate the size of the veterinary implant devices market includes the following details.

The market sizing was undertaken from the global side.

Country-level Analysis: The size of the veterinary implant devices market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of implant devices in the overall veterinary medical devices market was obtained from secondary data and validated by primary participants to arrive at the total market. Primary participants further validated the numbers.

Geographic Market Assessment (By Region and Country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual implant device segments by end user and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall veterinary implant devices market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

The above-mentioned data was consolidated and added with detailed input and analysis from MarketsandMarkets and presented in this report.

Veterinary Implant Devices Market: Top-Down and Bottom-Up Approach

Veterinary Implant Devices Market Top Down and Bottom Up Approach

Data Triangulation

After arriving at the overall size of the global veterinary implant devices market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

Market Definition

Veterinary implant devices are medical devices placed fully or partially inside an animal's body, surgically, by injection, or orally in the case of intraruminal boluses, and left in place to repair or replace anatomical structures, support organ function, deliver drugs or hormones over time, or monitor physiological and behavioral parameters.

Key Stakeholders

  • Veterinary implant device manufacturers and suppliers
  • Animal health pharmaceutical companies
  • Veterinarians and veterinary surgeons
  • Livestock farms, feedlots, and dairy production operators
  • Contract research organizations and biotechnology companies
  • Veterinary research institutes and academic institutions
  • Wildlife and conservation organizations, zoos, and aquarium personnel
  • Regulatory bodies
  • Government animal health agencies
  • Venture capitalists and investors
  • Market research and consulting firms
  • Corporate entities

Report Objectives

  • To describe, analyze, and forecast the veterinary implant devices market, by implant device, application, animal type, end user, and region, in terms of value
  • To forecast the market size, by implant device, in terms of value
  • To describe and forecast the veterinary implant devices market in key regions, namely North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa, in terms of value
  • To provide detailed information regarding drivers, restraints, opportunities, and challenges influencing the market growth
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
  • To profile key players and comprehensively analyze their market shares and core competencies in the market
  • To analyze competitive developments, such as partnerships, collaborations, agreements, acquisitions, product launches, expansions, and research and development activities, in the market
  • To analyze the impact of AI and Gen AI on the market in terms of capabilities, potential applications, use cases, and future opportunities

Available customizations:

With the given market data, MarketsandMarkets offers customizations as per the company's specific needs. The following customization options are available for the report:

Geographic Analysis

  • Further breakdown of the Rest of Europe veterinary implant devices market into the Netherlands, Switzerland, Russia, Poland, and other countries
  • Further breakdown of the Rest of Asia Pacific veterinary implant devices market into Thailand, Vietnam, Indonesia, Taiwan, and other countries
  • Further breakdown of the Rest of Latin America veterinary implant devices market into Colombia, Chile, Peru, and other countries
  • Further breakdown of the Rest of Middle East & Africa veterinary implant devices market into Israel, Iran, Iraq, Jordan, and other countries

Company Information

  • Detailed analysis and profiling of up to five additional market players

Product Analysis

  • Product matrix providing a detailed comparison of the implant device portfolios of the top five companies

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Veterinary Implants Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Veterinary Implants Devices Market

DMCA.com Protection Status
popup img